On Tuesday morning, Eli Lilly reported that orforglipron met the benchmarks of the companys Phase III ATTAIN-2 study
After you reach your goal weight, youll move into the maintenance phase with continual virtual visits with your care team to help you sustain your weight loss
Consent for publication Consents for publications of patients clinical data and images were obtained
Over five years, the researchers found: Osteoporosis developed in about 4.1 percent of GLP-1 users, compared with 3.2 percent of nonusers a roughly 29 percent higher relative risk
Insulin is essential but constant insulin is a problem Insulin is vital
The typical hurdles our patients are facing is first, getting covered by When asked what steps need to be taken to solve the current GLP-1 medication shortage, Cutler said that fixing it is a complex task due to the complexity of pharmaceutical licensure, manufacturing, and distribution